EDAP TMS SA (EDAP) Stock Price

EDAPStock

$3.99−53.34%52W

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta-0.01

EDAP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)4.51%

Price vs S&P 500 (4W)-2.99%

VGM Score47.40

Book Value / Share (Quarterly)$0.30

P/TBV (Annual)6.81x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)16.97%

Cash Flow / Share (Quarterly)$-0.59

Price vs S&P 500 (YTD)14.51%

Gross Margin (TTM)46.63%

Net Profit Margin (TTM)-44.51%

EPS (TTM)$-0.93

10-Day Avg Trading Volume0.05M

EPS Excl Extra (TTM)$-0.93

Revenue Growth (5Y)9.45%

EPS (Annual)$-0.88

ROI (Annual)-66.44%

Gross Margin (Annual)42.54%

Net Profit Margin (5Y Avg)-18.06%

Cash / Share (Quarterly)$0.45

Revenue Growth QoQ (YoY)31.38%

ROA (Last FY)-37.02%

Revenue Growth TTM (YoY)9.65%

EBITD / Share (TTM)$-0.65

ROE (5Y Avg)-47.80%

Operating Margin (TTM)-37.25%

Cash Flow / Share (Annual)$-0.66

P/B Ratio15.36x

P/B Ratio (Quarterly)13.80x

Net Income / Employee (Annual)$-113,598

EV / Revenue (TTM)2.37x

Net Interest Coverage (TTM)-17.72x

ROA (TTM)-40.94%

EV / EBITDA (TTM)358.91x

EPS Incl Extra (Annual)$-0.88

Current Ratio (Annual)1.54x

Quick Ratio (Quarterly)0.99x

3-Month Avg Trading Volume0.09M

52-Week Price Return-53.34%

Revenue / Employee (TTM)$270,862

Tangible BV / Share (Quarterly)$0.25

P/S Ratio (Annual)2.20x

Asset Turnover (Annual)0.89x

52-Week High$7.18

Operating Margin (5Y Avg)-16.75%

EPS Excl Extra (Annual)$-0.88

CapEx CAGR (5Y)55.18%

Tangible BV CAGR (5Y)-7.13%

26-Week Price Return17.00%

Quick Ratio (Annual)1.16x

13-Week Price Return-22.80%

Total Debt / Equity (Annual)1.27x

Current Ratio (Quarterly)1.34x

Enterprise Value$185.33M

Revenue / Share Growth (5Y)4.44%

Asset Turnover (TTM)0.92x

Book Value / Share Growth (5Y)-10.48%

Revenue / Employee (Annual)$273,892

Inventory Turnover (Annual)2.53x

Pretax Margin (Annual)-40.85%

Cash / Share (Annual)$0.61

3-Month Return Std Dev56.98%

Gross Margin (5Y Avg)43.93%

Net Income / Employee (TTM)$-120,558

ROE (Last FY)-150.65%

Net Interest Coverage (Annual)-2.72x

EPS Basic Excl Extra (Annual)$-0.88

P/FCF (TTM)22.89x

Receivables Turnover (TTM)3.89x

Total Debt / Equity (Quarterly)2.47x

EPS Incl Extra (TTM)$-0.93

Receivables Turnover (Annual)3.47x

ROI (TTM)-80.27%

P/S Ratio (TTM)2.22x

Pretax Margin (5Y Avg)-17.06%

Revenue / Share (Annual)$2.11

Tangible BV / Share (Annual)$0.53

Price vs S&P 500 (52W)-58.78%

Year-to-Date Return25.53%

5-Day Price Return-1.43%

EPS Normalized (Annual)$-0.88

ROA (5Y Avg)-17.03%

Net Profit Margin (Annual)-41.47%

Month-to-Date Return-3.28%

EBITD / Share (Annual)$-0.64

Operating Margin (Annual)-35.01%

LT Debt / Equity (Annual)0.82x

ROI (5Y Avg)-28.02%

LT Debt / Equity (Quarterly)1.74x

EPS Basic Excl Extra (TTM)$-0.93

P/TBV (Quarterly)16.64x

P/B Ratio (Annual)6.18x

Inventory Turnover (TTM)2.70x

Pretax Margin (TTM)-43.88%

Book Value / Share (Annual)$0.58

Price vs S&P 500 (13W)-25.61%

Beta-0.01x

P/FCF (Annual)39.18x

Revenue / Share (TTM)$2.09

ROE (TTM)-138.72%

52-Week Low$1.96

vGradeD

gGradeC

mGradeC

vgmGradeC

EDAP Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	May 7, 2026	-$0.24	-$0.27	-11.63%(-$0.02)
Q4 2025	Mar 25, 2026	-$0.18	-$0.29	-62.38%(-$0.11)
Q3 2025	Nov 6, 2025	-$0.29	-$0.17	+42.76%(+$0.12)
Q2 2025	Aug 28, 2025	-$0.18	-$0.20	-6.17%(-$0.01)

EDAP Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.89

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
EDAPEDAP TMS SA	D	C	C	2.2x	9.4%	46.6%	-37.3%	$3.99
MDTMedtronic plc	B	C	B	3.2x	3.8%	65.7%	18.1%	$94.75
ITGRInteger Holdings Corporation	C	C	A	2.3x	11.6%	26.1%	9.7%	$126.70
LIVNLivaNova PLC Ordinary Shares	C	B	B	2.9x	8.2%	68.1%	12.5%	$77.58
TMDXTransMedics Group, Inc. Common Stock	C	B	D	3.7x	88.2%	58.7%	12.2%	$70.78
AXGNAxogen, Inc. Common Stock	F	B	B	8.1x	14.9%	74.6%	-11.8%	$34.62
BLFSBioLife Solutions Inc.	F	C	A	18.4x	14.9%	63.9%	2.9%	$38.61
CNMDCONMED Corporation	B	C	B	1.0x	9.8%	55.8%	8.0%	$46.72
CBLLCeriBell, Inc. Common Stock	F	A	A	9.4x	—	88.9%	-68.6%	$25.04
INMDInMode Ltd. Ordinary Shares	A	D	C	2.2x	12.4%	76.5%	18.5%	$14.16
CVCapsoVision, Inc. Common Stock	F	D	B	25.0x	—	50.9%	-217.1%	$6.53
ELMDElectromed, Inc.	C	B	C	3.1x	15.6%	78.5%	18.8%	$27.42
FOCLEDAP TMS S.A. American Depositary Shares	C	C	D	2.3x	9.4%	47.6%	-40.7%	$4.09
STXSStereotaxis, Inc. Common Stock	D	F	D	3.4x	4.0%	55.6%	-75.7%	$1.01
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	29.9x	—	36.4%	-1004.7%	$1.12
NRXSNeuraxis, Inc.	F	A	A	18.2x	13.1%	85.5%	-144.5%	$7.70
STEXStreamex Corp. Common Stock	—	C	F	298.3x	—	100.0%	-10384.3%	$0.37
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	4.8x	115.2%	51.4%	-203.3%	$0.75
OMOutset Medical, Inc. Common Stock	A	C	C	0.6x	19.1%	41.8%	-56.1%	$3.94
ECORelectroCore, Inc. Common Stock	C	A	B	1.9x	55.7%	87.5%	-37.6%	$7.85
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	1.5x	24.2%	17.2%	-11.1%	$4.32
QTIQT Imaging Holdings, Inc. Common Stock	C	A	D	1.3x	—	40.4%	-56.2%	$2.40
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	50.5x	—	60.9%	-1776.4%	$3.84
IRIXIridex Corp	B	D	D	0.3x	7.7%	35.9%	-5.4%	$0.81
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	19.2x	—	51.4%	-1921.6%	$4.74
NXLNexalin Technology, Inc. Common Stock	D	D	F	11.3x	4.4%	86.2%	-4202.4%	$2.35
NUWENuwellis, Inc. Common Stock	—	D	F	0.2x	2.1%	69.7%	-142.9%	$0.55
EYESCorgi Data & Surveillance ETF	—	C	C	—	—	—	—	$28.78
FONRFonar Corporation	B	D	B	1.3x	4.0%	40.3%	9.1%	$0.00
MASIMasimo Corporation	D	D	B	6.0x	6.0%	61.7%	19.9%	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	—	—	—	—	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	8.4x	13.2%	-58.1%	-1549.0%	$2.49

About EDAP TMS SA

Edap TMS SA develops and markets ultrasound-based medical devices for urology and oncology, with three core divisions: HIFU technology for minimally invasive tumor treatment, ESWL systems for kidney stone lithotripsy, and a distribution channel for complementary medical products. The company generates revenue from both proprietary device sales and service of its global installed base across North America, Europe, and Asia.